179 related articles for article (PubMed ID: 30138647)
1. Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Bradley JA; Kayton ML; Chi YY; Hawkins DS; Tian J; Breneman J; Wolden SL; Walterhouse D; Rodeberg DA; Donaldson SS
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):19-27. PubMed ID: 30138647
[TBL] [Abstract][Full Text] [Related]
2. Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group.
Casey DL; Chi YY; Donaldson SS; Hawkins DS; Tian J; Arndt CA; Rodeberg DA; Routh JC; Lautz TB; Gupta AA; Yock TI; Wolden SL
Cancer; 2019 Sep; 125(18):3242-3248. PubMed ID: 31174239
[TBL] [Abstract][Full Text] [Related]
3. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group.
Malempati S; Rodeberg DA; Donaldson SS; Lyden ER; Anderson JR; Hawkins DS; Arndt CA
Cancer; 2011 Aug; 117(15):3493-501. PubMed ID: 21264837
[TBL] [Abstract][Full Text] [Related]
5. Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Rodeberg DA; Wharam MD; Lyden ER; Stoner JA; Brown K; Wolden SL; Paidas CN; Donaldson SS; Hawkins DS; Spunt SL; Arndt CA
Int J Cancer; 2015 Jul; 137(1):204-11. PubMed ID: 25418440
[TBL] [Abstract][Full Text] [Related]
6. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
8. 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Ermoian RP; Breneman J; Walterhouse DO; Chi YY; Meza J; Anderson J; Hawkins DS; Hayes-Jordan AA; Parham DM; Yock TI; Donaldson SS; Wolden SL
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28548706
[TBL] [Abstract][Full Text] [Related]
9. Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.
Walterhouse DO; Meza JL; Breneman JC; Donaldson SS; Hayes-Jordan A; Pappo AS; Arndt C; Raney RB; Meyer WH; Hawkins DS
Pediatr Blood Cancer; 2011 Jul; 57(1):76-83. PubMed ID: 21298768
[TBL] [Abstract][Full Text] [Related]
10. Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Lautz TB; Xue W; Luo LY; Fair D; Qumseya A; Gao Z; Dasgupta R; Rodeberg D; Venkatramani R
Pediatr Blood Cancer; 2023 Jul; 70(7):e30357. PubMed ID: 37070563
[TBL] [Abstract][Full Text] [Related]
11. Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
Doyen J; Jazmati D; Geismar D; Frisch S; Schleithoff SS; Vermeren X; Scheer M; Blase C; Tippelt S; Timmermann B
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1043-1054. PubMed ID: 31419513
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group.
Aye JM; Xue W; Palmer JD; Walterhouse DO; Arnold MA; Heaton TE; Venkatramani R
Pediatr Blood Cancer; 2021 Apr; 68(4):e28914. PubMed ID: 33501771
[TBL] [Abstract][Full Text] [Related]
13. Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients.
Regine WF; Fontanesi J; Kumar P; Ayers D; Bowman LC; Pappo AS; Coffey DH; Avery L; Rao BN; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):485-91. PubMed ID: 7852110
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma.
Regine WF; Fontanesi J; Kumar P; Zeitzer K; Greenwald C; Bowman L; Shapiro DN; Rao BN; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):799-805. PubMed ID: 7860391
[TBL] [Abstract][Full Text] [Related]
15. Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group.
Million L; Anderson J; Breneman J; Hawkins DS; Laurie F; Michalski J; Rodeberg D; Wharam M; Wolden S; Donaldson SS;
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):333-8. PubMed ID: 20646841
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.
Indelicato DJ; Rotondo RL; Krasin MJ; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Morris CG; Bradley JA
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):968-976. PubMed ID: 31987977
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
[TBL] [Abstract][Full Text] [Related]
18. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.
Smith LM; Anderson JR; Qualman SJ; Crist WM; Paidas CN; Teot LA; Pappo AS; Link MP; Grier HE; Wiener ES; Breneman JC; Raney RB; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Oct; 19(20):4058-64. PubMed ID: 11600608
[TBL] [Abstract][Full Text] [Related]
19. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
[TBL] [Abstract][Full Text] [Related]
20. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
